Categories: Activities, Jobs, News

Commonwealth Fund’s Request for Proposals (RFP)

I am reaching out regarding the Commonwealth Fund’s current Request for Proposals (RFP).  Based on your research priorities and previous publications I thought this opportunity may be of interest.

While our healthcare system is facing unprecedented times and we all adapt our work and lives for the new reality in which we find ourselves, we also want to continue the longstanding research agenda that we and our grantees have been pursuing.  As this pandemic has shown us, addressing the problems of our healthcare system are more important than ever.  It is in this vein that the Fund’s program on Controlling Health Care Costs seeks Letters of Intent (LOIs) addressing changes in investment and performance of pharmaceutical research and development, and the implications of high drug pricing and Medicare drug proposals on different patient populations. More details about the funding opportunity and research questions can be found in the RFP Overview document.

Initial application materials will be accepted until May 29, 2020, at 1:00 p.m. EST. Should disruptions due to COVID-19 make this deadline unreasonable, please email by May 15, 2020.

Kindly forward this opportunity to anyone in your network who may also be interested. In an effort to reach a broader set of grantees outside of the Fund’s existing network, this opportunity is only open to investigators who have not previously been the PI on a Fund grant. All interested applicants will be able to submit an LOI through the online portal, linked below, and selected LOIs will be invited to submit a full proposal.  

Please direct all programmatic questions to Answers to all questions will be posted weekly to a webpage linked below. All technical questions about the application portal should be directed to

Following are links to RFP resources:

All of us at the Commonwealth Fund send our best wishes to you, your colleagues, and your families during these trying times and hope that you are healthy and safe.

Eric C. Schneider, MD, FACP 
Senior Vice President for Policy and Research